We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter Spotlights Latest Advancements in Laboratory Diagnostics at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022

Beckman Coulter, Inc. More...

(Brea, CA, USA) will highlight its latest medical advancements in laboratory solutions at the 2022 AACC Clinical Lab Expo that streamline workflows, enhance productivity and bring automation to labs of all sizes. The company will also give live presentation on sepsis diagnosis and management highlighting the use of standardized laboratory and clinical operations in the context of a patient’s journey from initial assessment in the Emergency Department through treatment in the Intensive Care Unit (ICU) to eventual discharge.

At AACC 2022, Beckman Coulter is providing a booth tour to allow visitors to experience the total solution in the laboratory and an innovation tour to experience the future in healthcare. The company will be demonstrating the new DxA 5000 Fit Workflow Automation System, an automation solution that fundamentally improves lab workflow by making intelligent automation accessible to fit small- and mid-sized lab needs. The DxA 5000 Fit drives speed and accuracy, all while maintaining a small footprint. It eliminates up to 80% of the manual steps associated with processing a patient sample, allowing users to focus on patient care.

Among its portfolio of clinical informatics solutions, Beckman Coulter is demonstrating the DxONE Information Management Solutions. This includes the DxONE Inventory Manager, an automated, end-to-end software application that increases operational efficiency by automatically recording, tracking and optimizing a laboratory’s consumables; the new DxONE Workflow Manager which is the industry’s first cloud-based middleware solution that allows users to amplify productivity and future-proof their lab; the DxONE Command Central that allows labs to establish a centralized point of control connecting up to 18 instruments or automation systems across the network; and the DxONE Insights, a cloud-based software solution that provides actionable insights and lab data analytics to streamline operations, allowing labs to identify patterns and reduce inefficiencies.

Beckman Coulter is also demonstrating its range of scalable clinical chemistry analyzers that can help optimize a lab’s uptime, reliability and performance, including the AU480 chemistry analyzer which is the ideal primary clinical chemistry analyzer for low- to mid-volume hospitals and laboratories, or dedicated specialty chemistry or STAT analyzer for larger laboratories; the DxC 700 AU clinical chemistry analyzer for mid- to high-volume laboratories that combines the features of the DxC and AU series of clinical chemistry analyzers; and the AU5800 series clinical chemistry analyzers that are the fastest in the industry, processing up to 2,000 tests per hour with a full menu of assays.

Among its hematology solutions, Beckman Coulter is presenting the DxH 900 hematology analyzer that enables high-volume laboratories to achieve superb RBC, PLT and WBC differentials through near native-state cellular characterization; the DxH 690T 5-part differential CBC analyzer that delivers rapid patient results, while enabling technologists to simplify processes and reduce manual tasks; and the new DxH 560 AL hematology analyzer that helps save time and resources, eliminate manual intervention and deliver high-quality results, even for difficult-draw patient groups.
 

Related Links:
Beckman Coulter, Inc. 


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Pan-Cancer Panel
TruSight Oncology 500
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.